IMVT Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-09 | Barnett Eva Renee | officer: Chief Financial Officer | 371,709 | S-Sale | D | 3,689 | 31.18 | 115,023.00 |
| 2024-04-09 | Butchko Julia G. | officer: Chief Development Officer | 461,742 | S-Sale | D | 1,053 | 31.18 | 32,833.00 |
| 2024-04-09 | Salzmann Peter | director, officer: Chief Executive Officer | 1,086,958 | S-Sale | D | 4,807 | 31.18 | 149,882.00 |
| 2024-04-02 | Fromkin Andrew J. | director | 99,913 | A-Award | A | 11,255 | 0.00 | 0.00 |
| 2024-04-02 | Fromkin Andrew J. | director | 4,690 | A-Award | A | 4,690 | 30.78 | 144,358.00 |
| 2024-04-02 | Hughes Douglas J. | director | 125,010 | A-Award | A | 11,255 | 0.00 | 0.00 |
| 2024-04-02 | Hughes Douglas J. | director | 4,690 | A-Award | A | 4,690 | 30.78 | 144,358.00 |
| 2024-04-02 | MIGAUSKY GEORGE V | director | 121,063 | A-Award | A | 11,255 | 0.00 | 0.00 |
| 2024-04-02 | MIGAUSKY GEORGE V | director | 4,690 | A-Award | A | 4,690 | 30.78 | 144,358.00 |
| 2024-04-02 | Pande Atul | director | 94,413 | A-Award | A | 11,255 | 0.00 | 0.00 |
| 2024-04-02 | Pande Atul | director | 4,690 | A-Award | A | 4,690 | 30.78 | 144,358.00 |
| 2024-04-02 | Torti Frank | director | 635,674 | A-Award | A | 120,400 | 0.00 | 0.00 |
| 2024-04-02 | Torti Frank | director | 50,167 | A-Award | A | 50,167 | 30.78 | 1,544,140.00 |
| 2024-04-02 | Stout Jay S | officer: Chief Technology Officer | 154,978 | A-Award | A | 54,978 | 0.00 | 0.00 |
| 2024-04-02 | Stout Jay S | officer: Chief Technology Officer | 68,723 | A-Award | A | 68,723 | 30.78 | 2,115,294.00 |
| 2024-04-02 | Levine Mark S. | officer: Chief Legal Officer | 356,946 | A-Award | A | 54,978 | 0.00 | 0.00 |
| 2024-04-02 | Levine Mark S. | officer: Chief Legal Officer | 68,723 | A-Award | A | 68,723 | 30.78 | 2,115,294.00 |
| 2024-04-02 | Macias William L. | officer: Chief Medical Officer | 385,930 | A-Award | A | 54,978 | 0.00 | 0.00 |
| 2024-04-02 | Macias William L. | officer: Chief Medical Officer | 68,723 | A-Award | A | 68,723 | 30.78 | 2,115,294.00 |
| 2024-04-02 | Geffner Michael | officer: Chief Medical Officer | 144,877 | A-Award | A | 54,978 | 0.00 | 0.00 |
| 2024-04-02 | Geffner Michael | officer: Chief Medical Officer | 68,723 | A-Award | A | 68,723 | 30.78 | 2,115,294.00 |
| 2024-04-02 | Butchko Julia G. | officer: Chief Development Officer | 462,795 | A-Award | A | 54,978 | 0.00 | 0.00 |
| 2024-04-02 | Butchko Julia G. | officer: Chief Development Officer | 68,723 | A-Award | A | 68,723 | 30.78 | 2,115,294.00 |
| 2024-04-02 | Barnett Eva Renee | officer: Chief Financial Officer | 375,398 | A-Award | A | 54,978 | 0.00 | 0.00 |
| 2024-04-02 | Barnett Eva Renee | officer: Chief Financial Officer | 68,723 | A-Award | A | 68,723 | 30.78 | 2,115,294.00 |
| 2024-04-02 | Salzmann Peter | director, officer: Chief Executive Officer | 1,091,765 | A-Award | A | 160,534 | 0.00 | 0.00 |
| 2024-04-02 | Salzmann Peter | director, officer: Chief Executive Officer | 200,667 | A-Award | A | 200,667 | 30.78 | 6,176,530.00 |
| 2024-02-22 | Barnett Eva Renee | officer: Chief Financial Officer | 320,420 | S-Sale | D | 2,930 | 36.15 | 105,920.00 |
| 2024-02-22 | Levine Mark S. | officer: Chief Legal Officer | 301,968 | S-Sale | D | 2,134 | 36.15 | 77,144.00 |
| 2024-02-22 | Macias William L. | officer: Chief Medical Officer | 330,952 | S-Sale | D | 2,221 | 36.15 | 80,289.00 |
| 2024-02-22 | Butchko Julia G. | officer: Chief Development Officer | 407,817 | S-Sale | D | 2,146 | 36.15 | 77,578.00 |
| 2024-02-22 | Salzmann Peter | director, officer: Chief Executive Officer | 931,231 | S-Sale | D | 13,454 | 36.15 | 486,362.00 |
| 2024-01-26 | Levine Mark S. | officer: Chief Legal Officer | 304,148 | S-Sale | D | 2,981 | 37.91 | 113,010.00 |
| 2024-01-26 | Levine Mark S. | officer: Chief Legal Officer | 304,102 | S-Sale | D | 46 | 38.45 | 1,769.00 |
| 2024-01-26 | Geffner Michael | officer: Chief Medical Officer | 90,052 | S-Sale | D | 9,948 | 37.91 | 377,129.00 |
| 2024-01-26 | Geffner Michael | officer: Chief Medical Officer | 89,899 | S-Sale | D | 153 | 38.45 | 5,883.00 |
| 2024-01-18 | Macias William L. | officer: Chief Medical Officer | 333,173 | S-Sale | D | 424 | 41.03 | 17,397.00 |
| 2024-01-16 | Geffner Michael | officer: Chief Medical Officer* | 100,000 | D | 0 | 0.00 | 0.00 | |
| 2024-01-17 | Geffner Michael | officer: Chief Medical Officer* | 0 | D | 150,000 | 18.06 | 2,709,000.00 | |
| 2024-01-11 | Barnett Eva Renee | officer: Chief Financial Officer | 324,184 | S-Sale | D | 2,681 | 41.64 | 111,637.00 |
| 2024-01-11 | Barnett Eva Renee | officer: Chief Financial Officer | 323,350 | S-Sale | D | 834 | 42.43 | 35,387.00 |
| 2024-01-05 | Butchko Julia G. | officer: Chief Development Officer | 409,963 | S-Sale | D | 1,297 | 38.59 | 50,051.00 |
| 2024-01-05 | Salzmann Peter | director, officer: Chief Executive Officer | 944,685 | S-Sale | D | 3,824 | 38.59 | 147,568.00 |
| 2023-12-01 | Fromkin Andrew J. | director | 97,067 | S-Sale | D | 3,941 | 38.78 | 152,832.00 |
| 2023-12-01 | Fromkin Andrew J. | director | 93,431 | S-Sale | D | 3,636 | 39.81 | 144,749.00 |
| 2023-12-01 | Fromkin Andrew J. | director | 88,658 | S-Sale | D | 4,773 | 40.46 | 193,116.00 |
| 2023-12-01 | Pande Atul | director | 91,379 | S-Sale | D | 4,129 | 38.80 | 160,205.00 |
| 2023-12-01 | Pande Atul | director | 88,005 | S-Sale | D | 3,374 | 39.82 | 134,353.00 |
| 2023-12-01 | Pande Atul | director | 83,158 | S-Sale | D | 4,847 | 40.46 | 196,110.00 |
| 2023-12-01 | MIGAUSKY GEORGE V | director | 118,308 | S-Sale | D | 4,200 | 38.79 | 162,918.00 |
| 2023-12-01 | MIGAUSKY GEORGE V | director | 114,830 | S-Sale | D | 3,478 | 39.81 | 138,459.00 |
| 2023-12-01 | MIGAUSKY GEORGE V | director | 109,808 | S-Sale | D | 5,022 | 40.46 | 203,190.00 |
| 2023-11-22 | Salzmann Peter | director, officer: Chief Executive Officer | 949,125 | S-Sale | D | 15,601 | 32.75 | 510,933.00 |
| 2023-11-22 | Salzmann Peter | director, officer: Chief Executive Officer | 948,509 | S-Sale | D | 616 | 33.52 | 20,648.00 |
| 2023-11-22 | Barnett Eva Renee | officer: Chief Financial Officer | 327,019 | S-Sale | D | 3,901 | 32.75 | 127,758.00 |
| 2023-11-22 | Barnett Eva Renee | officer: Chief Financial Officer | 326,865 | S-Sale | D | 154 | 33.52 | 5,162.00 |
| 2023-11-22 | Butchko Julia G. | officer: Chief Development Officer | 411,384 | S-Sale | D | 3,141 | 32.75 | 102,868.00 |
| 2023-11-22 | Butchko Julia G. | officer: Chief Development Officer | 411,260 | S-Sale | D | 124 | 33.52 | 4,156.00 |
| 2023-11-22 | Macias William L. | officer: Chief Medical Officer | 333,721 | S-Sale | D | 3,141 | 32.75 | 102,868.00 |
| 2023-11-22 | Macias William L. | officer: Chief Medical Officer | 333,597 | S-Sale | D | 124 | 33.52 | 4,156.00 |
| 2023-11-22 | Levine Mark S. | officer: Chief Legal Officer | 307,253 | S-Sale | D | 3,128 | 32.75 | 102,442.00 |
| 2023-11-22 | Levine Mark S. | officer: Chief Legal Officer | 307,129 | S-Sale | D | 124 | 33.52 | 4,156.00 |
| 2023-10-25 | Levine Mark S. | officer: Chief Legal Officer | 310,381 | S-Sale | D | 4,107 | 34.66 | 142,349.00 |
| 2023-10-19 | Macias William L. | officer: Chief Medical Officer | 336,862 | S-Sale | D | 530 | 36.80 | 19,504.00 |
| 2023-10-10 | Barnett Eva Renee | officer: Chief Financial Officer | 330,920 | S-Sale | D | 4,557 | 36.92 | 168,244.00 |
| 2023-10-05 | Butchko Julia G. | officer: Chief Development Officer | 415,964 | S-Sale | D | 296 | 35.54 | 10,520.00 |
| 2023-10-05 | Butchko Julia G. | officer: Chief Development Officer | 414,525 | S-Sale | D | 1,439 | 36.39 | 52,365.00 |
| 2023-10-05 | Salzmann Peter | director, officer: Chief Executive Officer | 969,071 | S-Sale | D | 894 | 35.54 | 31,773.00 |
| 2023-10-05 | Salzmann Peter | director, officer: Chief Executive Officer | 964,726 | S-Sale | D | 4,345 | 36.39 | 158,115.00 |
| 2023-10-02 | Roivant Sciences Ltd. | director, 10 percent owner: | 79,805,331 | P-Purchase | A | 1,526,316 | 38.00 | 58,000,008.00 |
| 2023-10-02 | Roivant Sciences Ltd. | director, 10 percent owner: | 78,279,015 | A-Award | A | 4,473,684 | 38.00 | 169,999,992.00 |
| 2023-08-30 | Salzmann Peter | director, officer: Chief Executive Officer | 975,873 | S-Sale | D | 50,866 | 21.97 | 1,117,526.00 |
| 2023-08-30 | Salzmann Peter | director, officer: Chief Executive Officer | 969,965 | S-Sale | D | 5,908 | 22.48 | 132,812.00 |
| 2023-08-24 | Levine Mark S. | officer: Chief Legal Officer | 314,489 | S-Sale | D | 12,285 | 20.30 | 249,386.00 |
| 2023-08-24 | Levine Mark S. | officer: Chief Legal Officer | 314,488 | S-Sale | D | 1 | 20.89 | 20.89 |
| 2023-08-24 | Barnett Eva Renee | officer: Chief Financial Officer | 335,478 | S-Sale | D | 14,385 | 20.30 | 292,016.00 |
| 2023-08-24 | Barnett Eva Renee | officer: Chief Financial Officer | 335,477 | S-Sale | D | 1 | 20.89 | 20.89 |
| 2023-08-24 | Butchko Julia G. | officer: Chief Development Officer | 416,261 | S-Sale | D | 12,332 | 20.30 | 250,340.00 |
| 2023-08-24 | Butchko Julia G. | officer: Chief Development Officer | 416,260 | S-Sale | D | 1 | 20.89 | 20.89 |
| 2023-08-24 | Macias William L. | officer: Chief Medical Officer | 337,393 | S-Sale | D | 12,332 | 20.30 | 250,340.00 |
| 2023-08-24 | Macias William L. | officer: Chief Medical Officer | 337,392 | S-Sale | D | 1 | 20.89 | 20.89 |
| 2023-08-14 | Salzmann Peter | director, officer: Chief Executive Officer | 1,038,053 | S-Sale | D | 91,744 | 21.34 | 1,957,817.00 |
| 2023-08-14 | Salzmann Peter | director, officer: Chief Executive Officer | 1,026,739 | S-Sale | D | 11,314 | 22.04 | 249,361.00 |
| 2023-08-07 | Salzmann Peter | director, officer: Chief Executive Officer | 1,129,797 | S-Sale | D | 101,339 | 21.73 | 2,202,096.00 |
| 2023-07-26 | Levine Mark S. | officer: Chief Legal Officer | 326,774 | S-Sale | D | 3,917 | 21.63 | 84,725.00 |
| 2023-07-19 | Macias William L. | officer: Chief Medical Officer | 349,725 | S-Sale | D | 426 | 24.94 | 10,624.00 |
| 2023-07-19 | Barnett Eva Renee | officer: Chief Financial Officer | 349,863 | S-Sale | D | 2,725 | 24.94 | 67,962.00 |
| 2023-07-12 | Salzmann Peter | director, officer: Chief Executive Officer | 1,231,136 | S-Sale | D | 3,233 | 19.73 | 63,787.00 |
| 2023-07-12 | Butchko Julia G. | officer: Chief Development Officer | 428,593 | S-Sale | D | 1,470 | 19.73 | 29,003.00 |
| 2023-04-25 | Macias William L. | officer: Chief Medical Officer | 350,151 | S-Sale | D | 509 | 16.29 | 8,292.00 |
| 2023-04-25 | Levine Mark S. | officer: Chief Legal Officer | 330,691 | S-Sale | D | 2,633 | 16.29 | 42,892.00 |
| 2023-04-17 | Stout Jay S | officer: Chief Technology Officer | 150,000 | A-Award | A | 150,000 | 15.47 | 2,320,500.00 |
| 2023-04-17 | Stout Jay S | officer: Chief Technology Officer | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2023-04-17 | Stout Jay S | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-04-18 | Barnett Eva Renee | officer: Chief Financial Officer | 352,588 | S-Sale | D | 3,423 | 15.27 | 52,269.00 |
| 2023-04-18 | Butchko Julia G. | officer: Chief Development Officer | 430,063 | S-Sale | D | 1,544 | 15.27 | 23,577.00 |
| 2023-04-18 | Salzmann Peter | director, officer: Chief Executive Officer | 1,234,369 | S-Sale | D | 3,395 | 15.27 | 51,842.00 |
| 2023-04-12 | Pande Atul | director | 95,508 | A-Award | A | 12,523 | 0.00 | 0.00 |
| 2023-04-12 | Pande Atul | director | 16,260 | A-Award | A | 16,260 | 14.70 | 239,022.00 |
| 2023-04-12 | Hughes Douglas J. | director | 113,755 | A-Award | A | 12,523 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
